ADVENTRX Pharmaceuticals (ANX) – Analyst Ratings
-
Dawson James Starts Adventrx Pharmaceuticals (ANX) at Market Outperform
-
Rodman & Renshaw Hikes Price Target On Adventrx Pharmaceuticals (ANX) to $16
-
-
-
-
-
-
Back to ANX Stock Lookup